Virtus ETF Advisers’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,485
Closed -$59.8K 791
2024
Q4
$59.8K Sell
1,485
-286
-16% -$16.3K 0.02% 451
2024
Q3
$112K Buy
1,771
+33
+2% +$1.94K 0.05% 360
2024
Q2
$92.1K Sell
1,738
-2,773
-61% -$182K 0.05% 350
2024
Q1
$370K Sell
4,511
-306
-6% -$13.6K 0.2% 206
2023
Q4
$89.6K Buy
4,817
+399
+9% +$5.22K 0.06% 405
2023
Q3
$48.9K Sell
4,418
-439
-9% -$6.28K 0.03% 416
2023
Q2
$78.7K Buy
+4,857
New +$102K 0.05% 430
2022
Q2
Sell
-32,708
Closed -$98K 476
2022
Q1
$98K Sell
32,708
-1,945
-6% -$6.98K 0.04% 307
2021
Q4
$159K Sell
34,653
-318
-0.9% -$1.78K 0.06% 328
2021
Q3
$220K Sell
34,971
-1,820
-5% -$11.2K 0.1% 244
2021
Q2
$220K Sell
36,791
-7,964
-18% -$47.3K 0.09% 276
2021
Q1
$283K Buy
44,755
+789
+2% +$5.55K 0.12% 251
2020
Q4
$248K Buy
43,966
+1,459
+3% +$8.84K 0.1% 315
2020
Q3
$247K Sell
42,507
-5,813
-12% -$40K 0.13% 267
2020
Q2
$348K Buy
48,320
+3,100
+7% +$20.6K 0.16% 266
2020
Q1
$212K Sell
45,220
-6,603
-13% -$40.6K 0.09% 273
2019
Q4
$416K Buy
51,823
+19,672
+61% +$143K 0.07% 243
2019
Q3
$221K Sell
32,151
-1,790
-5% -$13.3K 0.04% 231
2019
Q2
$282K Buy
33,941
+5,087
+18% +$43.5K 0.06% 244
2019
Q1
$287K Sell
28,854
-3,457
-11% -$28.9K 0.61% 62
2018
Q4
$247K Sell
32,311
-7,649
-19% -$91.5K 0.04% 161
2018
Q3
$696K Sell
39,960
-29,345
-42% -$349K 0.08% 77
2018
Q2
$658K Buy
+69,305
New +$461K 0.58% 119

Other funds holding VKTX